Pharmacy benefit managers (PBMs) are up to bat in the perpetual blame game between PBMs and the pharmaceutical industry. | ...

Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...

The speed of medicine has changed. Healthcare professionals are no longer waiting for conferences or clinical guidelines to make key decisions. In fast-paced clinical settings, physicians are actively ...

Here are some of the current challenges we're facing in content creation and how we can solve them by being smart with how we ...

(Nasdaq: GILD) announced today its first quarter 2025 results of operations. "Gilead had a strong start to the year driven by ...

Pharma executives emphasise that without urgent action, Europe may face a decline and an acceleration in the departure of ...

There are only four sustainable growth engines: performance marketing, virality, content, and sales. Most breakout companies ...

Klick Health, a digital marketing agency for the health industry, is exploring the sale of a minority stake, people familiar ...

Interpublic Group reiterated its 2025 organic revenue guidance and tried to assure analysts that it’s capable of handling any potential downturn.

Rights Mar 16, 2016 Mar 17, 2016 May 12, 2015 Rights ratio: 5 share for every 116 held at a price of Rs 245.0 Rights Aug 23, 2012-Jul 14, 2011 Rights ratio: 1 share for every 7 held at a price of Rs ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,862.54 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...